Hello,



  • This field is for validation purposes and should be left unchanged.
EECO2 Privacy Policy

NEW CASE STUDY – RECIRCULATION FEASIBILITY STUDY AT API R&D FACILITY

Following identification of a potential project in the ESOS report, EECO2 Ltd was appointed to carry out a detailed feasibility study, for the recirculation of air from the exhaust system back to the supply air handling unit (AHU) at this Active Pharmaceutical Ingredient – API R&D facility. 

The report concluded that with a structured, risk-based approach, energy savings of £80,000 per year can be delivered, with a payback less than 2 years. API facilities have great potential for improving safety monitoring while achieving more efficient HVAC operation following a systematic risk-based approach to project development.

To read more about how the EECO2 team developed the project savings, take a look at the case study.

API R&D

Does you API R&D site require an energy efficiency assessment or feasibility study? Get in touch with EECO2 and see what we can do for you!

Follow EECO2 on Twitter or LinkedIn for more News Updates like this one – “Recirculation Feasibility Study at API R&D Facility”.


sign up to the eecO2 knowledge hub

By completing this form, you confirm that we may contact you via email, that you are over the age of 16 and that we can send you periodic emails, containing useful and interesting information including our email newsletter. Please see our privacy policy for more information and to see how you can manage your consent.

OUR CLIENTS

AbbVie

Aesica

ALKERMES

Allergan

Amgen

AstraZeneca

BAYER

Catalent

Eli Lilly

GlaxoSmithKline

Novartis

Pfizer

Pharmavite

Purogenix

Sanofi